NewsHK
health insurers have spent much of the year under pressure over medical-cost trends, with investors in managed care treating each quarterly result as a live read on whether utilization is running hotter than the pricing built into annual contracts.
Humana beat quarterly earnings estimates and held its full-year 2026 adjusted profit outlook at a minimum of $9 per share, the company reporting that medical costs came in line with its own expectations.
Some analysts, working from elevated expectations for the sector, called the unchanged guidance a disappointment.
The result and what it signals Humana's maintained guidance lands against a backdrop of sector-wide anxiety over medical-cost creep.
Keep reading